$19.04
-2.8%National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Solid cash generation: Positive free cash flow with reasonable earnings quality provides financial flexibility for growth investments, debt reduction, or shareholder returns.
NRC โข NASDAQ
| National Research Corporation Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
11.6M | 24.8M | 31M | 31.8M | 37.5M | 37.3M | 32.4M | 30M | 22.9M | 20.5M | 17.6M | 18.2M | 15.5M | 15.1M | 11.6M | 8.5M | 8.5M | 7.4M | 6.8M | 5.9M | |
7.6M | 6M | 5.9M | 5.3M | 6.4M | 7.5M | 5.5M | 5.5M | 4.6M | 4.2M | 4.1M | 3.8M | 3.7M | 4.7M | 5.1M | 4.7M | 3.8M | 2.7M | 2.6M | 2.3M | |
2.5M | -406K | -717K | -1.2M | 33K | 51K | 1.1M | 1.2M | -684K | 865K | -1.4M | 107K | 16K | -421K | 1.4M | 614K | 1.7M | 430.4K | 117K | 99.1K | |
3.3M | 284K | 935K | 1.2M | 623K | 680K | 1.2M | 1.5M | 1.8M | 1.9M | 1.4M | 742K | 955K | 388K | 763K | 779K | 619K | 1M | 0.0 | 0.0 | |
545K | 100K | -102K | 2.6M | 7K | -248K | -6K | 186K | 207K | -195K | -327K | 277K | 107K | 605K | -1K | 34K | 1K | 155.8K | 1.1M | 1.1M | |
(0.0) | (8.2M) | (8.9M) | (12.2M) | (10.6M) | (5.2M) | (6.9M) | (2.6M) | (12.8M) | (10M) | (9.4M) | (9.9M) | (8.2M) | (5.1M) | (3.4M) | (4.5M) | (3M) | (3.5M) | (0.0) | (0.0) | |
916K | 3.8M | 1M | -3.4M | 1.8M | -4.6M | 616K | 1.5M | -806K | -499K | 472K | 3.1M | -979K | -1.2M | -273K | -27K | -1M | 3.4M | 3.9M | -2.6M | |
26.5M | 34.6M | 38.1M | 36.3M | 46.3M | 40.6M | 40.9M | 39.8M | 28.1M | 26.8M | 21.9M | 26.2M | 19.3M | 19.1M | 18.5M | 14.6M | 13.7M | 15.2M | 14.6M | 6.8M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-10.7M | -15.4M | -15.8M | -9.8M | -5.5M | -4M | -4.7M | -6M | -4.8M | -4M | -2.9M | -2.5M | -2.2M | -2.3M | -2.8M | -1.5M | -2.9M | -2.8M | -2M | -1.5M | |
(0.0) | -4.8M | (0.0) | (0.0) | -3M | (0.0) | (0.0) | (0.0) | (0.0) | (223K) | (1.6M) | -2.6M | (0.0) | (0.0) | -4.1M | -15.4M | -93K | -12.6M | (0.0) | -20.6M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1.3M | (0.0) | (0.0) | -657K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3M | -1.4M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.7M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 99.5K | 4M | 9.8M | |
0.0 | 0.0 | 1K | 0.0 | 0.0 | 260K | -4.7M | -6M | -1.6M | 223K | 1.6M | -5.7M | -2.2M | 0.0 | -6.9M | -17M | 0.0 | 0.0 | 200.0 | 50.0 | |
-10.7M | -20.3M | -15.8M | -9.8M | -8.5M | -3.7M | -4.7M | -6M | -6.1M | -3.8M | -1.3M | -5.7M | -2.2M | -2.3M | -6.9M | -17M | -3M | -15.3M | -938.8K | -13.7M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-20M | -30.9M | -19.1M | -27.6M | -4.1M | 0.0 | -1.1M | -72.4M | -1.7M | -204K | -1.8M | -348K | -55K | -527K | -146K | -463K | -84K | -9M | 96.7K | -309.9K | |
16.1M | 26M | 14.2M | -4.8M | -4.6M | -3.9M | -3.9M | 36.8M | -2.6M | -2.3M | -2.5M | -2.4M | -2.2M | -2.2M | -1.8M | 8.5M | -5.2M | 9.6M | -8.1M | 9.6M | |
-11M | -11.5M | -36.4M | -21M | -9.2M | -10.5M | -31.3M | -16.9M | -16.9M | -28.6M | -10.1M | (0.0) | -2.1M | -17.4M | -5.9M | -5.1M | -4.3M | -3.8M | -3.3M | -2.8M | |
-20.2M | -30.9M | -19.1M | -27.6M | -4.1M | (0.0) | -1.1M | -72.4M | -1.7M | -204K | -1.8M | -348K | -55K | -527K | -146K | -463K | -84K | -9M | -241.1K | -1.2M | |
-923K | -359K | 576K | -2M | -275K | -1.1M | 0.0 | -2M | 0.0 | -1.5M | -2.5M | 1M | 1.6M | 2.1M | 975K | 320K | 17K | 679.8K | 80.3K | 341.5K | |
-15.8M | -16.8M | -40.7M | -55.6M | -18.2M | -15.5M | -36.3M | -54.5M | -21.1M | -32.5M | -16.9M | -1.7M | -2.8M | -16.7M | -6.9M | 3.3M | -9.5M | -1.8M | -11.2M | 6.9M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
0.0 | 0.0 | -1K | -182K | 3K | -236K | 611K | -1.1M | 855K | 285K | -1.6M | -794K | -497K | 107K | -105K | 130K | 287K | -402.6K | 97.7K | -9.2K | |
-94K | -2.4M | -18.4M | -29.3M | 19.7M | 21.2M | 526K | -21.7M | 1.7M | -9.1M | 2.1M | 18M | 13.8M | 204K | 4.6M | 1M | 1.4M | -2.2M | 2.5M | 32.4K | |
4.2M | 6.7M | 25M | 54.4M | 34.7M | 13.5M | 13M | 34.7M | 33M | 42.1M | 40M | 22.1M | 8.3M | 8.1M | 3.5M | 2.5M | 1.1M | 3.4M | 876.4K | 844K | |
4.1M | 4.2M | 6.7M | 25M | 54.4M | 34.7M | 13.5M | 13M | 34.7M | 33M | 42.1M | 40M | 22.1M | 8.3M | 8.1M | 3.5M | 2.5M | 1.1M | 3.4M | 876.4K | |
15.7M | 19.2M | 22.3M | 26.4M | 40.8M | 36.7M | 36.3M | 33.9M | 23.3M | 22.9M | 18.9M | 23.7M | 17.1M | 16.8M | 15.7M | 13.1M | 10.8M | 12.4M | 12.6M | 5.4M |
NRC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | May 08, 2026 | June 23, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 28, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 28, 2026 | April 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 20, 2026 | April 15, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 05, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 03, 2026 | February 03, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 |
Continue your NRC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.